GSK PLC's ticker is and the CUSIP is 37733W204. A total of 802 filers reported holding GSK PLC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,565,855 | +0.7% | 43,196 | -1.0% | 0.12% | +90.2% |
Q2 2023 | $1,554,688 | -0.9% | 43,622 | -1.1% | 0.06% | -56.7% |
Q1 2023 | $1,569,078 | +4.1% | 44,100 | +2.8% | 0.14% | -13.0% |
Q4 2022 | $1,507,963 | +16.2% | 42,913 | -2.7% | 0.16% | +165.6% |
Q3 2022 | $1,298,000 | -38.8% | 44,091 | -9.5% | 0.06% | -38.4% |
Q2 2022 | $2,122,000 | – | 48,741 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JTC Employer Solutions Trustee Ltd | 12,444,460 | $451,112 | 41.96% |
Eversept Partners, LP | 3,259,342 | $118,151,148 | 10.00% |
Sio Capital Management, LLC | 509,000 | $18,451,250 | 5.71% |
Callodine Capital Management, LP | 475,000 | $17,218,750 | 4.80% |
EQUITY INVESTMENT CORP | 3,277,362 | $118,804,373 | 3.70% |
Clean Yield Group | 207,739 | $7,802,677 | 3.46% |
Robinson Value Management, Ltd. | 128,116 | $4,644,205 | 3.46% |
Camber Capital Management LP | 2,850,000 | $103,313 | 3.40% |
Hillman Capital Management, Inc. | 232,864 | $8,441,320 | 3.25% |
Soleus Capital Management, L.P. | 943,000 | $34,183,750 | 3.15% |